carteolol
Selected indexed studies
- Carteolol. (, 2006) [PMID:30000575]
- Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension. (Drugs Aging, 2007) [PMID:17571916]
- Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension. (Drugs Aging, 1992) [PMID:1554974]
_Worker-drafted node — pending editorial review._
Connections
carteolol is a side effect of
Sources
- Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism. (1990) pubmed
- Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis. (2016) pubmed
- Carteolol. (2006) pubmed
- Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension. (2007) pubmed
- Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension. (1992) pubmed
- Carteolol triggers senescence via activation of β-arrestin-ERK-NOX4-ROS pathway in human corneal endothelial cells in vitro. (2023) pubmed
- 0.01% atropine combined with carteolol hydrochloride can inhibit the scleral remodeling in guinea pigs with form-deprivation myopia. (2025) pubmed
- Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops. (2023) pubmed
- Efficacy of topical 2% carteolol in the treatment of infantile hemangiomas: a dermoscopic and clinical evaluation. (2025) pubmed
- Beta-blocker carteolol and oxprenolol produce cutaneous analgesia in response to needle pinpricks in the rat. (2023) pubmed